<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Hirsutism – Primary Care Algorithm (NICE CKS 2024)</title>
  <style>
    :root {
      --bg: #f7f8fb;
      --card: #ffffff;
      --ink: #1f2937;          /* neutral-800 */
      --muted: #6b7280;        /* neutral-500 */
      --primary: #2563eb;      /* blue-600 */
      --accent: #0891b2;       /* cyan-600 */
      --ok: #059669;           /* emerald-600 */
      --warn: #d97706;         /* amber-600 */
      --danger: #dc2626;       /* red-600 */
      --border: #e5e7eb;       /* neutral-200 */
      --shadow: 0 10px 25px rgba(31,41,55,.06), 0 4px 10px rgba(31,41,55,.05);
      --radius: 18px;
    }

    * { box-sizing: border-box; }
    html, body { height: 100%; }
    body {
      margin: 0;
      font-family: ui-sans-serif, system-ui, -apple-system, "Segoe UI", Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      color: var(--ink);
      background: linear-gradient(180deg, #ffffff 0%, var(--bg) 100%);
    }

    /* Header */
    header {
      position: sticky;
      top: 0;
      z-index: 50;
      background: rgba(255,255,255,0.8);
      backdrop-filter: saturate(160%) blur(8px);
      border-bottom: 1px solid var(--border);
    }
    .navbar {
      max-width: 1100px;
      margin: 0 auto;
      padding: 14px 20px;
      display: flex;
      align-items: center;
      gap: 14px;
      justify-content: space-between;
    }
    .brand {
      display: flex; align-items: center; gap: 12px; text-decoration: none;
      color: var(--ink);
    }
    .brand svg { width: 36px; height: 36px; }
    .brand h1 { font-size: clamp(1.05rem, 1.2vw + .9rem, 1.35rem); margin: 0; letter-spacing: .2px; }
    .toolbar { display: flex; gap: 8px; align-items: center; }
    .btn {
      border: 1px solid var(--border);
      background: var(--card);
      color: var(--ink);
      padding: 10px 14px;
      border-radius: 12px;
      font-weight: 600; font-size: .95rem;
      box-shadow: var(--shadow);
      cursor: pointer;
    }
    .btn.primary { background: var(--primary); color: white; border-color: transparent; }
    .btn:hover { filter: brightness(0.98); }

    main { max-width: 1100px; margin: 32px auto; padding: 0 20px 32px; }

    /* Intro Card */
    .intro {
      background: var(--card);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      box-shadow: var(--shadow);
      padding: 22px;
      display: grid; gap: 12px;
    }
    .intro h2 { margin: 0; font-size: 1.3rem; }
    .meta { color: var(--muted); font-size: .95rem; display: flex; gap: 18px; flex-wrap: wrap; }

    /* Grid */
    .grid {
      margin-top: 22px;
      display: grid;
      grid-template-columns: repeat(12, 1fr);
      gap: 18px;
    }

    .card {
      grid-column: span 12;
      background: var(--card);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      box-shadow: var(--shadow);
      padding: 22px 22px 16px;
    }

    @media (min-width: 980px) {
      .card.split-7 { grid-column: span 7; }
      .card.split-5 { grid-column: span 5; }
      .card.split-6 { grid-column: span 6; }
    }

    .card h3 { margin: 0 0 10px; font-size: 1.12rem; display: flex; align-items: center; gap: 8px; }
    .card p { margin: 10px 0; color: var(--ink); }
    .muted { color: var(--muted); }

    /* List styles */
    .list { margin: 0; padding-left: 18px; }
    .list li { margin: 6px 0; }

    /* Numbered steps */
    .step { display: flex; gap: 12px; align-items: flex-start; margin: 9px 0; }
    .badge {
      flex: 0 0 auto;
      width: 28px; height: 28px; border-radius: 50%;
      background: var(--primary); color: #fff; display: grid; place-content: center;
      font-weight: 700; font-size: .95rem; box-shadow: var(--shadow);
    }

    /* Callouts */
    .callout {
      border-left: 5px solid var(--accent);
      background: #f0f9ff;
      padding: 12px 14px;
      border-radius: 12px;
      margin: 10px 0;
    }
    .callout.warn { border-color: var(--warn); background: #fff8eb; }
    .callout.danger { border-color: var(--danger); background: #fff1f2; }
    .callout.ok { border-color: var(--ok); background: #ecfdf5; }

    /* Definition list layout for compact bullets */
    .kv { display: grid; grid-template-columns: max-content 1fr; gap: 4px 14px; }
    .kv dt { font-weight: 700; }
    .kv dd { margin: 0; }

    /* Footer */
    footer {
      margin-top: 24px; color: var(--muted); font-size: .92rem; text-align: center;
    }

    /* Print optimisations (A4) */
    @media print {
      :root { --shadow: none; }
      header, .toolbar { display: none !important; }
      main { max-width: 100%; margin: 0; padding: 0; }
      body { background: #fff; }
      .card, .intro { break-inside: avoid; page-break-inside: avoid; box-shadow: none; }
    }
  </style>
</head>
<body>
  <header>
    <nav class="navbar">
      <a class="brand" href="#top" aria-label="Hirsutism Algorithm Home">
        <!-- Simple inline logo -->
        <svg viewBox="0 0 48 48" fill="none" aria-hidden="true">
          <defs>
            <linearGradient id="g" x1="0" y1="0" x2="1" y2="1">
              <stop offset="0%" stop-color="#60a5fa"/>
              <stop offset="100%" stop-color="#06b6d4"/>
            </linearGradient>
          </defs>
          <rect x="4" y="4" width="40" height="40" rx="12" fill="url(#g)"/>
          <path d="M16 30c4-6 6-6 10-12 2-3 6-3 6 1 0 8-9 11-12 15-2 2-6 0-4-4Z" fill="#fff"/>
        </svg>
        <h1>Hirsutism – Primary Care Algorithm</h1>
      </a>
      <div class="toolbar">
        <button class="btn" onclick="window.print()" title="Print or save to PDF">Print</button>
        <a class="btn primary" href="#algorithm">Jump to Algorithm</a>
      </div>
    </nav>
  </header>

  <main id="top">
    <!-- Intro / Summary -->
    <section class="intro" role="region" aria-labelledby="s-intro">
      <h2 id="s-intro">At‑a‑Glance</h2>
      <p class="muted">Based on NICE CKS (October 2024): primary care management of hirsutism in women ≥18 years.</p>
      <div class="kv" aria-label="Scope and audience">
        <dt>Scope</dt><dd>Diagnosis, initial investigations, and first‑line management in primary care.</dd>
        <dt>Audience</dt><dd>Busy clinicians seeking a rapid decision aid at the point of care.</dd>
        <dt>Key principle</dt><dd>Triage red flags early; treat by severity & quality‑of‑life impact; consider referral thresholds.</dd>
      </div>
    </section>

    <div class="grid" id="algorithm">
      <!-- Initial Assessment -->
      <section class="card split-7" role="region" aria-labelledby="s-initial">
        <h3 id="s-initial">Initial Assessment</h3>
        <div class="step"><span class="badge">1</span>
          <div>
            <strong>History</strong>: onset & progression; menstrual/ovulatory history; fertility; drugs (danazol, valproate, anabolic steroids, etc.); systemic clues (PCOS, Cushing’s, thyroid, prolactin, acromegaly); family history.
          </div>
        </div>
        <div class="step"><span class="badge">2</span>
          <div>
            <strong>Examination</strong>: distribution of terminal hair (vs vellus); <em>Ferriman‑Gallwey</em> scoring (≥8 typical threshold; adjust for ethnicity); signs of virilization (voice deepening, clitoromegaly, ↑muscle bulk); BMI/central adiposity; <em>QoL impact</em>.
          </div>
        </div>
        <div class="callout ok" role="note"><strong>Tip:</strong> Treatment decisions depend on <em>patient‑reported distress</em> as much as the numerical score.</div>
      </section>

      <!-- Red Flags -->
      <section class="card split-5" role="region" aria-labelledby="s-urgent">
        <h3 id="s-urgent">
          <!-- icon -->
          <svg width="18" height="18" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 8v5m0 3h.01M10.29 3.86 1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0Z" stroke="var(--danger)" stroke-width="1.6" stroke-linecap="round" stroke-linejoin="round"/></svg>
          Red Flags – <span class="muted">Urgent Endocrine Referral (&lt;2 weeks)</span>
        </h3>
        <ul class="list">
          <li>Sudden or rapid progression of hair growth.</li>
          <li>Virilization: deep voice, ↑muscle bulk, clitoromegaly.</li>
          <li>Pelvic/abdominal mass.</li>
          <li>Total testosterone &gt; <strong>6–7 nmol/L</strong> (or strong suspicion of androgen‑secreting tumour).</li>
        </ul>
      </section>

      <!-- Investigations -->
      <section class="card split-6" role="region" aria-labelledby="s-tests">
        <h3 id="s-tests">Investigations (when indicated)</h3>
        <ul class="list">
          <li><strong>Total testosterone</strong> (reliable specialty assay) in abnormal score or local sexual hair with clinical endocrine signs.</li>
          <li>If moderate/severe or discordant features → add <strong>total &amp; free testosterone</strong> (AM sample).</li>
          <li><strong>17‑hydroxyprogesterone</strong> (AM, follicular phase) to screen for non‑classical CAH in hyperandrogenaemia/high‑risk groups (e.g., Ashkenazi Jewish, Hispanic, Eastern European) or positive FHx.</li>
          <li>Consider TSH, prolactin, and tests for Cushing’s/acromegaly <span class="muted">based on clinical suspicion</span>.</li>
          <li><strong>No tests</strong> if mild, localized, stable growth with normal score and no endocrine features.</li>
        </ul>
      </section>

      <!-- Differentials -->
      <section class="card split-6" role="region" aria-labelledby="s-ddx">
        <h3 id="s-ddx">Differential Diagnosis</h3>
        <div class="callout">
          <strong>Hirsutism</strong>: androgen‑dependent distribution (face, chest, abdomen, lower back, upper arms, thighs).
          <br/>
          <strong>Hypertrichosis</strong>: generalized, non‑sexual pattern; congenital, systemic (hypothyroid, porphyria, etc.) or drug‑induced (minoxidil, ciclosporin, glucocorticoids, phenytoin).
        </div>
      </section>

      <!-- Management Premenopausal -->
      <section class="card split-7" role="region" aria-labelledby="s-pre">
        <h3 id="s-pre">Management – Premenopausal</h3>
        <div class="step"><span class="badge">1</span><div>
          <strong>Foundational</strong>: lifestyle/weight loss if overweight or obese; discuss ongoing cosmetic hair reduction (shaving, waxing, depilatories, bleaching; or electrolysis/laser for longer‑term reduction).
        </div></div>
        <div class="step"><span class="badge">2</span><div>
          <strong>Mild facial</strong>: topical <strong>eflornithine 11.5% cream</strong> — results in 6–8 weeks; <em>stop if no benefit by 4 months</em>; benefits reverse ≈8 weeks after stopping.
        </div></div>
        <div class="step"><span class="badge">3</span><div>
          <strong>Wider/severe</strong>: offer a <strong>COC containing ethinylestradiol</strong> (prefer <span class="muted">lowest effective EE dose (≈20 µg) + low‑VTE‑risk progestogen</span> in higher VTE risk patients). Discuss VTE risks and standard COC contraindications.
          <div class="callout warn" style="margin-top:8px"><strong>Note:</strong> Use of COCs for hirsutism is off‑label except <em>Dianette®</em> (cyproterone/EE) which is licensed for moderate–severe hirsutism. <strong>Avoid</strong> any cyproterone‑containing medication if there is a history of meningioma.</div>
        </div></div>
        <div class="step"><span class="badge">4</span><div>
          <strong>Refer to specialist</strong> if COC is contraindicated or ineffective after ≥6 months.
        </div></div>
      </section>

      <!-- Management Postmenopausal -->
      <section class="card split-5" role="region" aria-labelledby="s-post">
        <h3 id="s-post">Management – Postmenopausal</h3>
        <ul class="list">
          <li>Cosmetic methods remain central; encourage weight optimisation where appropriate.</li>
          <li><strong>Eflornithine</strong> for facial hair (as above).</li>
          <li>Otherwise <strong>refer</strong> for specialist evaluation/treatment.</li>
        </ul>
      </section>

      <!-- Non-urgent Referral thresholds -->
      <section class="card split-12" role="region" aria-labelledby="s-ref">
        <h3 id="s-ref">When to Refer (Non‑Urgent)</h3>
        <div class="grid" style="gap:12px">
          <div class="card split-6" style="padding:16px">
            <h3 style="margin-top:0;font-size:1rem">Biochemical/Investigational</h3>
            <ul class="list">
              <li>Total testosterone <strong>4–6 nmol/L</strong> (or higher if persistent on repeat).</li>
              <li>Elevated <strong>17‑hydroxyprogesterone</strong> or abnormal endocrine testing.</li>
            </ul>
          </div>
          <div class="card split-6" style="padding:16px">
            <h3 style="margin-top:0;font-size:1rem">Clinical</h3>
            <ul class="list">
              <li>Suspected endocrine disorder needing secondary care diagnosis/management.</li>
              <li>Failure of primary care therapy (e.g., COC after ≥6 months, or intolerance/contraindication).</li>
            </ul>
          </div>
        </div>
      </section>

      <!-- Prescribing notes -->
      <section class="card split-12" role="region" aria-labelledby="s-rx">
        <h3 id="s-rx">Prescribing Notes – Eflornithine 11.5% (Vaniqa®)</h3>
        <div class="grid" style="gap:12px">
          <div class="card split-6" style="padding:16px">
            <h3 style="margin-top:0;font-size:1rem">How to Use</h3>
            <ul class="list">
              <li>Apply <strong>thin layer BID</strong> (≥8 h apart) to <em>face/under chin only</em>; rub in thoroughly.</li>
              <li>Cosmetics after 5 min; avoid washing the area for 4 h post‑application.</li>
              <li>May combine with shaving/waxing (apply ≥5 min after hair removal).</li>
            </ul>
          </div>
          <div class="card split-6" style="padding:16px">
            <h3 style="margin-top:0;font-size:1rem">Safety</h3>
            <ul class="list">
              <li><strong>Do not use</strong> in pregnancy, breastfeeding, or &lt;19 years.</li>
              <li>Common AEs: mild acne, irritation, erythema; reduce to daily if irritated; stop if persistent.</li>
              <li>No known drug interactions.</li>
            </ul>
          </div>
        </div>
      </section>
    </div>

    <footer>
      <p>Content summarised for rapid clinical reference from NICE Clinical Knowledge Summaries: <em>Hirsutism</em>, last revised October 2024. This page is a concise aid and does not replace full guidance or clinical judgement.</p>
    </footer>
  </main>

  <script>
    // Smooth anchor scrolling
    document.querySelectorAll('a[href^="#"]').forEach(a => {
      a.addEventListener('click', e => {
        const id = a.getAttribute('href');
        const el = document.querySelector(id);
        if (el) { e.preventDefault(); el.scrollIntoView({behavior:'smooth', block:'start'}); }
      })
    });
  </script>
</body>
</html>
